ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

tert-Butyl 4-(4-(9-(4-fluorophenyl)-3-oxo-3,7,8,9-tetrahydro-2H-pyrido[4,3,2-de]phthalazin-8-yl)benzyl)-2-methylpiperazine-1-carboxylate → 9-(4-Fluorophenyl)-8-(4((3-methylpiperazin-1-yl)methyl)phenyl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one

HRID 1467686
印刷

反応式

HRID 1467686 の反応式
C(OC([N:8]1[CH2:13][CH2:12][N:11]([CH2:14][C:15]2[CH:20]=[CH:19][C:18]([CH:21]3[NH:33][C:31]4[C:32]5[C:23](=[N:24][NH:25][C:26](=[O:34])[C:27]=5[CH:28]=[CH:29][CH:30]=4)[CH:22]3[C:35]3[CH:40]=[CH:39][C:38]([F:41])=[CH:37][CH:36]=3)=[CH:17][CH:16]=2)[CH2:10][CH:9]1[CH3:42])=O)(C)(C)C>Cl.C(#N)C>[F:41][C:38]1[CH:37]=[CH:36][C:35]([CH:22]2[C:23]3=[N:24][NH:25][C:26](=[O:34])[C:27]4[CH:28]=[CH:29][CH:30]=[C:31]([C:32]=43)[NH:33][CH:21]2[C:18]2[CH:19]=[CH:20][C:15]([CH2:14][N:11]3[CH2:12][CH2:13][NH:8][CH:9]([CH3:42])[CH2:10]3)=[CH:16][CH:17]=2)=[CH:40][CH:39]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

3

反応物 1

HCID 136374676tert-Butyl 4-(4-(9-(4-fluorophenyl)-3-oxo-3,7,8,9-tetrahydro-2H-pyrido[4,3,2-de]phthalazin-8-yl)benzyl)-2-methylpiperazine-1-carboxylate

生成物 1

HCID 1361863069-(4-Fluorophenyl)-8-(4((3-methylpiperazin-1-yl)methyl)phenyl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one収率 52%

試薬・触媒・溶媒 1

HCID 22261314Acetonitrile--hydrogen chloride (1/1)溶媒

実験手順

A mixture of tert-butyl-4-(4-(9-(4-fluorophenyl)-3-oxo-3,7,8,9-tetrahydro-2H-pyrido[4,3,2-de]phthalazin-8-yl)benzyl)-2-methylpiperazine-1-carboxylate (70 mg, 0.123 mole) in 2 ml of HCl-acetonitrile was stirred for 2 hours. Concentrated and the residue was purified by prep-HPLC to afford the title produce as a white solid (30 mg, yield 52%). 1H-NMR (400 MHz, DMSO-d) δ (ppm): 0.87 (d, J=6.4 Hz, 3H), 1.49 (t, J=10 Hz, 1H), 1.83 (t, J=10 Hz, 1H), 2.55 (m, 2H), 2.64 (m, 2H), 2.75 (m, 1H), 3.32 (s, 3H), 4.34 (d, J=9.2 Hz, 1H), 4.72 (d, J=9.2 Hz, 1H), 6.97-7.01 (m, 2H), 7.13-7.24 (m, 7H), 7.37-7.41 (m, 2H), 7.55-7.59 (m, 1H), 12.15 (s, 1H); LC-MS (ESI) m/z: 470 (M+1)+.

後処理

  1. concentrationConcentrated
  2. customthe residue was purified by prep-HPLC
  3. customto afford the title

出典と根拠

ORDレコード
ord-aec8bb7dfd4147d7be21cb539bef093b
出典データセット
uspto-grants-2015_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08999987B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート